Interleukin-1 polymorphism and treatment response in HCV patients

This book represents the first study on the correlation between IL-1 (+3953 C/T) gene polymorphism and the response of INF-therapy in genotype 4 HCV infected patients. The results encourages us to further assess this single nucleotide polymorphism as a marker for prediction of response to therapy and disease progression which would have great implications in saving money, time and avoiding unnecessary adverse effects.

Autorentext

Dr. Moatza Hassan Omran, Associate Professor of Biomedical Biotechenology, National Research Center. Noha El-Sayed Ibrahim Sayed Ahmed, Researcher Assistant, National Research Center.

Klappentext

This book represents the first study on the correlation between IL-1 (+3953 C/T) gene polymorphism and the response of INF-therapy in genotype 4 HCV infected patients. The results encourages us to further assess this single nucleotide polymorphism as a marker for prediction of response to therapy and disease progression which would have great implications in saving money, time and avoiding unnecessary adverse effects.